Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the western blotting data shown in Figs. 1C and 6D bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that some of the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors agree with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 33: 774‑782, 2015; DOI: 10.3892/or.2014.3623].

中文翻译：

---

[已撤稿] 基于真核共表达质粒的 STAT3 特异性 siRNA 和 LKB1 在体外和体内对卵巢癌的协同作用。

在这篇论文发表后，一位相关读者引起了编辑的注意，图中所示的某些蛋白质印迹数据。1C 和 6D 与不同作者在其他文章中以不同形式出现的数据有着意想不到的相似之处。由于上述文章中的一些有争议的数据在提交给Oncology Reports之前已经在其他地方发表，或者已经在考虑发表，编辑决定从期刊上撤回这篇论文。作者同意撤回论文的决定。给读者带来的不便，编者深表歉意。[原文发表于Oncology Reports 33: 774‑782, 2015; DOI：10.3892/或.2014.3623]。